Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Touchi Extract
- Development stage
- Unknown
- Lead developer
- Nippon Supplement
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Touchi Extract is a water-soluble extract derived from fermented soybeans, primarily used for its alpha-glucosidase inhibitory activity. It helps manage blood glucose levels by slowing carbohydrate digestion, which is beneficial for individuals with non-insulin-dependent diabetes mellitus. It also has effects on lipid metabolism and may aid in wound healing.
- Other names
- Fermented black bean extractFermented black soybean extract
02
Targets
Sucrase-Isomaltase
Beyond the preview
Go deeper on Touchi Extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Touchi Extract.